ABBOTT LABORATORIES — Director's Dealing 2008

Jul 23, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-07-21

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-07-21	Common shares without par value	M	10128	$42.4978	Acquired	1137848	Direct
2008-07-21	Common shares without par value	M	224097	$44.60	Acquired	1361945	Direct
2008-07-21	Common shares without par value	M	558628	$45.4488	Acquired	1920573	Direct
2008-07-21	Common shares without par value	F	689212	$57.58	Disposed	1231361	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-07-21	Option (right to buy)	$42.4978	M	10128	Disposed	2009-02-11	Common shares (10128)	Direct
2008-07-21	Option (right to buy)	$44.60	M	224097	Disposed	2010-02-10	Common shares (224097)	Direct
2008-07-21	Option (right to buy)	$45.4488	M	558628	Disposed	2011-02-08	Common shares (558628)	Direct
2008-07-21	Option (right to buy)	$57.58	A	8522	Acquired	2009-02-11	Common shares (8522)	Direct
2008-07-21	Option (right to buy)	$57.58	A	193509	Acquired	2010-02-10	Common shares (193509)	Direct
2008-07-21	Option (right to buy)	$57.58	A	487181	Acquired	2011-02-08	Common shares (487181)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	18251	Indirect
Common shares without par value	5168	Indirect
Common shares without par value	5168	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of July 18, 2008.

F2: The reporting person disclaims beneficial ownership of all securities held by his sons.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.